Senseonics Holdings (Senseonics Holdings) Cash-to-Debt : 2.29 (As of Dec. 2023)

View and export this data going back to 2016. Start your Free Trial

What is Senseonics Holdings Cash-to-Debt?

Cash to Debt Ratio measures the financial strength of a company. It is calculated as a company's cash, cash equivalents, and marketable securities divide by its debt. Senseonics Holdings's cash to debt ratio for the quarter that ended in Dec. 2023 was 2.29.

If Cash to Debt ratio is greater than 1, the company can pay off its debt using the cash in hand. Here we can see, Senseonics Holdings could pay off its debt using the cash in hand for the quarter that ended in Dec. 2023.

The historical rank and industry rank for Senseonics Holdings's Cash-to-Debt or its related term are showing as below:

SENS' s Cash-to-Debt Range Over the Past 10 Years
Min: 0.29 Med: 1.94 Max: No Debt
Current: 2.29

During the past 10 years, Senseonics Holdings's highest Cash to Debt Ratio was No Debt. The lowest was 0.29. And the median was 1.94.

SENS's Cash-to-Debt is ranked better than
51.8% of 861 companies
in the Medical Devices & Instruments industry
Industry Median: 1.91 vs SENS: 2.29

Senseonics Holdings Cash-to-Debt Historical Data

The historical data trend for Senseonics Holdings's Cash-to-Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Note: An indication of "No Debt" does not necessarily mean that the company has no debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.

* Premium members only.

Senseonics Holdings Cash-to-Debt Chart

Senseonics Holdings Annual Data

Trend

Jun14

Jun15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Cash-to-Debt

Get a 7-Day Free Trial

0.81

0.29

2.05

1.91

2.29

Senseonics Holdings Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Cash-to-Debt	Get a 7-Day Free Trial															1.91	3.16	2.56	2.66	2.29

Competitive Comparison of Senseonics Holdings's Cash-to-Debt

For the Medical Devices subindustry, Senseonics Holdings's Cash-to-Debt, along with its competitors' market caps and Cash-to-Debt data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Senseonics Holdings's Cash-to-Debt Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Senseonics Holdings's Cash-to-Debt distribution charts can be found below:

* The bar in red indicates where Senseonics Holdings's Cash-to-Debt falls into.

Senseonics Holdings Cash-to-Debt Calculation

This is the ratio of a company's Cash, Cash Equivalents, Marketable Securities to its debt. The debt includes the Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation. This ratio measures the financial strength of a company. This ratio is updated quarterly.

Senseonics Holdings's Cash to Debt Ratio for the fiscal year that ended in Dec. 2023 is calculated as:

Cash to Debt Ratio	=	Cash, Cash Equivalents, Marketable Securities	/	Total Debt
	=	Cash, Cash Equivalents, Marketable Securities	/	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)
	=	109.456	/	(0.368	+	47.409)
	=	2.29

Senseonics Holdings's Cash to Debt Ratio for the quarter that ended in Dec. 2023 is calculated as:

Cash to Debt Ratio	=	Cash, Cash Equivalents, Marketable Securities	/	Total Debt
	=	Cash, Cash Equivalents, Marketable Securities	/	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)
	=	109.456	/	(0.368	+	47.409)
	=	2.29

Senseonics Holdings (AMEX:SENS) Cash-to-Debt Explanation

If Cash to Debt ratio is greater than 1, the company can pay off its debt using the cash in hand. If it is smaller than 1, it means the company has more debt than the cash in hands. In this case, it is important to look the the company's Interest Coverage. Ben Graham requires that a company must have an Interest Coverage of at least 5.

Senseonics Holdings Cash-to-Debt Related Terms

Thank you for viewing the detailed overview of Senseonics Holdings's Cash-to-Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

Senseonics Holdings (Senseonics Holdings) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Senseonics Holdings Inc (AMEX:SENS) » Definitions » Cash-to-Debt

Comparable Companies

Traded in Other Exchanges

6L6:Germany 6L6:Germany

Address

20451 Seneca Meadows Parkway, Germantown, MD, USA, 20876-7005

Website

https://www.senseonics.com

Senseonics Holdings Inc is a medical technology company. It is focused on the design, development, and commercialization of the glucose monitoring system, which helps people to manage their diabetes community with differentiated, long-term implantable glucose management technology. Its products and services include a Continuous glucose monitoring system, Sensor, Smart transmitter, and Mobile app. The firm has a Glucose monitoring product segment. The majority of the revenue is generated outside of the United States.

Executives

Sharon Larkin	director	C/O SENSEONICS HOLDINGS, INC., 20451 SENECA MEADOWS PARKWAY, GERMANTOWN MD 20876
Douglas A Roeder	director	160 BOVET RD, SUITE 408, C/O DELPHI VENTURES, SAN MATEO CA 94402
Frederick T. Sullivan	officer: Chief Financial Officer	C/O SENSEONICS HOLDINGS, INC., 20451 SENECA MEADOWS PARKWAY, GERMANTOWN MD 20876
Mukul Jain	officer: VP Operations, Qual & Reg	20451 SENECA MEADOWS PARKWAY, GERMANTOWN MD 20876
Edward Fiorentino	director	1350 KENNICOTT DRIVE, LAKE FOREST IL 60045
Mirasol Panlilio	officer: VP Global Sales & Marketing	20451 SENECA MEADOWS PARKWAY, GERMANTOWN MD 20876
Timothy T Goodnow	director, officer: President & Chief Exec Officer	20451 SENECA MEADOWS PARKWAY, GERMANTOWN MD 20876
Francine Kaufman	officer: Chief Medical Officer	C/O SENSEONICS HOLDINGS, INC., 20451 SENECA MEADOWS PARKWAY, GERMANTOWN MD 20876
Kenneth L Horton	officer: GC & Corp. Development Advisor	VERTEX PHARMACEUTICALS INCORPORATED, 130 WAVERLY STREET, CAMBRIDGE MA 02139
Nick B. Tressler	officer: Chief Financial Officer	C/O SENSEONICS HOLDINGS, INC., 20451 SENECA MEADOWS PARKWAY, GERMANTOWN MD 208786
Anthony R. Raab	director	C/O SENSEONICS HOLDINGS, INC., 20451 SENECA MEADOWS PARKWAY, GERMANTOWN MD 20876
John Marotta	director	C/O SENSEONICS HOLDINGS, INC., 20451 SENECA MEADOWS PARKWAY, GERMANTOWN MD 20876
Stephen P Defalco	director	ONE EXETER STREET, BOSTON MA 02116
Douglas S Prince	director	20 TILESTON STREET, PH4, BOSTON MA 02113
Edelman Steven	director	C/O SENSEONICS HOLDINGS, INC., 20451 SENECA MEADOWS PARKWAY, GERMANTOWN MD 20876